Structure

InChI Key WOZSCQDILHKSGG-UHFFFAOYSA-N
Smile CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C
InChI
InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)

Physicochemical Descriptors

Property Name Value
Molecular Formula C20H32N5O8P
Molecular Weight 501.48
AlogP 2.7
Hydrogen Bond Acceptor 13.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 11.0
Polar Surface Area 166.98
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 34.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR DNA polymerase/reverse transcriptase inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
HIV Infections 3 D015658 ClinicalTrials
Cytomegalovirus Infections 3 D003586 ClinicalTrials

Related Entries

Scaffolds

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Musculoskeletal and connective tissue disorders
22.25
Metabolism and nutrition disorders
17.83
Renal and urinary disorders
15.34
Investigations
13.07
General disorders and administration site conditions
7.68
Injury, poisoning and procedural complications
5.67
Nervous system disorders
3.62
Hepatobiliary disorders
2.68

Cross References

Resources Reference
CAS NUMBER 142340-99-6
ChEBI 31175
ChEMBL CHEMBL922
DrugBank DB00718
DrugCentral 88
EPA CompTox DTXSID5046487
FDA SRS U6Q8Z01514
Human Metabolome Database HMDB0014856
PharmGKB PA10005
PubChem 60871
SureChEMBL SCHEMBL29729
ZINC ZINC000003930376